Skip to main content
ICONIC LABS PLC logo

ICONIC LABS PLC — Investor Relations & Filings

Ticker · ICON ISIN · GB00BRBJ3P08 LEI · 213800YCXZV6RSHGGT04 IL Financial and insurance activities
Filings indexed 629 across all filing types
Latest filing 2017-03-30 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL ICON

About ICONIC LABS PLC

https://www.iconiclabs.co.uk/

Iconic Labs PLC is a media and technology business focused on assembling a portfolio of cutting-edge companies. Its core strategy involves the identification, acquisition, and growth of technology-driven businesses operating in the online media, artificial intelligence, and big data sectors. The company targets lean, online companies that can scale rapidly and operate internationally with an inexpensive footprint. It seeks to invest in businesses that leverage information and video gathering, data mining, just-in-time processing, and online collaboration technology to provide a broad array of services.

Recent filings

Filing Released Lang Actions
Preliminary Results
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Unaudited Preliminary Results' for WideCells Group PLC for the period ended 31 December 2016. It contains a detailed 'Chairman's Statement', operational highlights, and business updates. While it is labeled 'Unaudited Preliminary Results', it functions as an interim/periodical financial report providing substantive analysis and financial context for the company's performance. It is not a mere announcement of a report (RPA) as it contains the actual content and narrative of the results. FY 2016
2017-03-30 English
Board Appointment
Board/Management Information Classification · 100% confidence The document is an official announcement from WideCells Group PLC regarding the appointment of a new Non-Executive Director to their Board. It details the professional background of the appointee and mentions the granting of share options. This falls squarely under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2017-02-16 English
New Revenue Stream: Stem Cell Research, Manchester
Regulatory Filings Classification · 98% confidence The document is an official announcement released via the Regulatory News Service (RNS) of the London Stock Exchange. It details a specific business development (a Letter of Intent with Qigenix) and contains inside information as per the Market Abuse Regulation. Since it is a general corporate announcement regarding business operations that does not fit into more specific categories like M&A (which usually implies a full takeover or merger) or financial reporting, it is classified as a general regulatory filing.
2016-11-30 English
LOI with 1st Cord Blood Bank to Roll Out CellPlan
Regulatory Filings Classification · 95% confidence The document is a press release issued via the London Stock Exchange's RNS (Regulatory News Service). It announces a non-binding Letter of Intent (LOI) between WideCells Group PLC and Biovault Technical Ltd regarding a commercial partnership. As this is a general corporate announcement regarding business operations and partnerships that does not fit into specific categories like M&A (which usually implies a takeover or merger of entities) or other specialized financial filings, it is classified as a Regulatory Filing (RNS).
2016-11-07 English
Corporate Update
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange. It provides a 'Corporate Update' covering personnel appointments, facility renovations, and a reference to a shareholder letter. While it mentions personnel, it is a general corporate update rather than a formal board change announcement (MANG). It does not fit into specific financial reporting categories like 10-K or IR, and it is not a report itself but a news release. Therefore, it falls under the RNS category.
2016-10-24 English
Update on CellPlan
Regulatory Filings Classification · 98% confidence The document is an official announcement from WideCells Group PLC regarding the finalization of terms for their 'CellPlan' insurance product, the establishment of new offices in Portugal, and new management appointments. It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. While it provides detailed information about the product, it is a corporate announcement of business developments rather than a formal financial report, audit, or investor presentation. Given the nature of the content as a regulatory announcement of company news, it falls under the RNS category.
2016-10-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.